Microcurrent Intensity Explained: µA, mA and Why It Matters for Results
About the Authors
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.
Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.
Andrew Conrad Barile, PT, DPT
Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine
Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.
Share
Why These Numbers Matter More Than You Think
Every facial device lists intensity specifications on its packaging. NuFace advertises 400 µA. Foreo Bear 2 claims 680 µA. Other devices reference milliamps, kilohertz, or simply "clinical strength" without defining what that means. For most consumers, these numbers are meaningless noise, and device marketers rely on that confusion to make apples-to-oranges comparisons sound meaningful.
In my practice, I've seen patients choose devices based entirely on whichever specification sounded "strongest," without understanding that the unit of measurement matters far more than the number itself. A device delivering 680 µA is not doing something fundamentally more powerful than one delivering 400 µA. But a device delivering 5 mA at 1,500 Hz is operating in a completely different physiological category than either of them.
Understanding the difference between microamps, milliamps, and frequency is the single most useful piece of knowledge you can bring to a device purchase decision. It takes five minutes to learn and saves hundreds of dollars in misguided purchases.
The Electrical Stimulation Spectrum
Electrical stimulation for facial treatment exists on a spectrum of intensity, and different ranges produce fundamentally different physiological effects:
Nanoamperes (nA): billionths of an ampere. This is the range used by devices like the ZIIP Halo in its "nanocurrent" protocols. At this intensity, the current theoretically mimics the body's own bioelectrical signaling. You feel nothing during treatment. There is no muscle response. The effect, if any, occurs at the individual cell level.
Microamperes (µA): millionths of an ampere. This is the range used by microcurrent devices like NuFace (400 µA) and Foreo Bear 2 (680 µA). The current stimulates cellular adenosine triphosphate (ATP) production and is believed to support tissue metabolism. You feel little to nothing during treatment. There is no visible muscle contraction. The stimulus is sub-sensory and sub-motor.
Milliamperes (mA): thousandths of an ampere. This is the range used by Electrical Muscle Stimulation (EMS) devices. At milliampere intensity delivered at appropriate frequencies (typically 1,000-2,000 Hz), the current crosses the motor contraction threshold, directly activating motor neurons and forcing involuntary muscle contraction. You feel your muscles contracting rhythmically. The contraction is visible and palpable.
The leap from microamperes to milliamperes is not incremental. It's categorical. One thousand microamperes equals one milliampere. A microcurrent device operating at 680 µA is operating at 0.68 mA, well below the threshold at which facial motor neurons fire reliably. An EMS device operating in the milliampere range at kilohertz frequencies produces a physiological response that is qualitatively different, not just quantitatively stronger.
Why Higher Microcurrent Is Not the Same as EMS
This is where device marketing creates the most confusion. When Foreo advertises "the most powerful microcurrent device at 680 µA," the implied message is that more microcurrent equals better results. If 400 µA produces subtle toning, surely 680 µA produces stronger toning.
The physiology doesn't support this reasoning. Here is why.
Motor neurons in facial muscles have a firing threshold, the minimum electrical stimulus required to trigger a contraction. Below that threshold, the neuron receives the signal but does not fire. It's binary: the neuron either fires and the muscle contracts, or it doesn't fire and nothing happens at the muscular level.
For facial muscles, the motor threshold requires current in the milliampere range delivered at specific frequencies and pulse widths. Whether you deliver 200 µA, 400 µA, or 680 µA, you remain below that threshold. You are varying the intensity of a sub-threshold stimulus. The muscle does not care whether you whisper at volume 4 or volume 7. Both are below the volume at which it responds.
This is why microcurrent devices, regardless of their specific µA output, produce similar categories of results: subtle cellular-level stimulation, mild ATP enhancement, temporary fluid redistribution, and modest toning that plateaus within weeks and reverses when you stop using the device. The difference between 400 µA and 680 µA exists on a spec sheet but may not translate to meaningful clinical difference.
The Role of Frequency
Intensity alone doesn't tell the full story. Frequency, measured in Hertz (Hz) or kilohertz (kHz), determines how many electrical pulses are delivered per second, and it plays a critical role in muscle activation.
Microcurrent devices typically operate at low frequencies, often below 600 Hz. At these frequencies, even if the current were somehow strong enough to reach the motor threshold, the pulse timing would be insufficient for sustained tetanic contraction, the smooth, continuous muscle engagement that produces a strength-training effect.
EMS devices for facial application operate in the kilohertz range, typically 1,000-2,000 Hz (1-2 kHz). At these frequencies, individual electrical pulses fuse into sustained muscle contraction, producing the same type of tetanic engagement that occurs during vigorous exercise. The muscle contracts fully and remains contracted through the stimulation period, maximizing the mechanical force and metabolic demand on the tissue.
PureLift LAB devices operate within a range of 1.37-1.73 kHz, which falls in the optimal window for facial muscle activation without causing discomfort.
Neural Accommodation: Why Frequency Variation Matters
There is a second dimension to frequency that matters beyond the base operating range: variation.
The human nervous system is exceptionally good at pattern recognition. When exposed to a repetitive electrical stimulus at a fixed frequency, the nervous system identifies the pattern and progressively dampens its response. This is neural accommodation, and it affects every form of repetitive electrical stimulation.
In practical terms, this means a fixed-frequency device becomes less effective with each session. The muscle contraction weakens. The user increases the intensity to compensate. Eventually, the maximum intensity is reached and the device has effectively plateaued.
Research by Avendano-Coy et al. (2019) studied this accommodation effect and found that randomized frequency modulation significantly reduced the nervous system's ability to adapt to the stimulus. When the frequency varies unpredictably across pulses, the nervous system cannot build a predictive model and cannot dampen its response.
Triple-Wave Randomized Frequency Modulation applies this principle by simultaneously varying three waveform parameters, frequency, pulse width, and amplitude envelope, in real time during each treatment session. The result is a stimulus that maintains full therapeutic contraction intensity throughout the session and across months of regular use, because the nervous system never encounters the same pattern twice.
This is the critical technical differentiator that separates a device that maintains its effectiveness from one that gradually becomes less effective over time, and it explains why some users report that their device "stopped working" after several months. The device didn't stop working. Their nervous system learned to ignore it.
What This Means for Your Purchase Decision
When evaluating facial devices, the specifications that actually predict results are:
Operating range: is the device in the microampere (µA) range or the milliampere (mA) range? This determines whether the device can cross the motor contraction threshold and produce involuntary muscle activation. Microcurrent devices (µA) cannot. EMS devices (mA) can.
Operating frequency: is the device in the low-frequency range (below 600 Hz) or the kilohertz range (1,000+ Hz)? Kilohertz frequencies produce the sustained tetanic contraction that builds muscle density.
Frequency variation: does the device use a fixed frequency or randomized frequency modulation? Fixed-frequency devices lose effectiveness over time due to neural accommodation. Randomized modulation maintains therapeutic efficacy indefinitely.
FDA clearance: has the device undergone regulatory review for its specific claims and application? FDA cleared 510(k) status means the device has been reviewed for safety and performance in its intended use category.
The µA number on a microcurrent device's packaging tells you how that device compares to other microcurrent devices. It does not tell you how it compares to EMS technology, because the two operate in fundamentally different physiological categories. Comparing 680 µA microcurrent to milliampere-range EMS is like comparing the brightness of a flashlight to a floodlight using the same scale. They illuminate different things at different intensities for different purposes.
Frequently Asked Questions
Can you use EMS and microcurrent together? You can, though there is limited clinical rationale for combining them. EMS already delivers electrical stimulation at intensities that encompass and exceed microcurrent's operating range. Adding microcurrent after an EMS session is redundant in terms of muscle activation, though some users find it useful for product absorption or relaxation.
Is higher µA always better for microcurrent? Not necessarily. The dose-response curve for ATP stimulation at microampere levels is not well established for facial applications. There is limited evidence that 680 µA produces meaningfully superior outcomes to 400 µA. The intensity difference matters less than the consistency of use.
Why don't microcurrent companies just increase their intensity to milliampere levels? Because crossing the motor contraction threshold changes the device category from cosmetic toning to medical-grade muscle stimulation, which requires different regulatory clearances, different safety engineering, different electrode designs, and fundamentally different expertise. Building an effective EMS device is not simply a matter of turning up the dial on a microcurrent device.
Are EMS devices safe for the face? FDA cleared 510(k) EMS devices designed specifically for facial application are safe when used as directed. The key factors are appropriate intensity limits, electrode design optimized for facial anatomy, and manufacturing quality. Made in Japan precision engineering standards provide the manufacturing consistency required for devices operating at therapeutic intensity near sensitive facial structures.
The Device That Operates Where It Matters
PureLift LAB's FDA cleared 510(k) EMS devices operate in the milliampere range at 1.37-1.73 kHz with Triple-Wave Randomized Frequency Modulation, delivering involuntary muscle contraction at therapeutic intensity that maintains its effectiveness session after session. Made in Japan precision engineering.
If you want the most technically advanced EMS system available for home use, the PureLift Glow ($999) combines clinical-grade EMS with the exclusive PDM++ waveform and integrated LED therapy.
If you want focused, professional-grade diamond-shaped probe EMS with the anti-accommodation waveform technology that makes the difference, the PureLift Pro ($699) delivers exactly that.